This message was sent to ##Email##
|
|
|
|
| |
The early bird rate, a savings of $100 USD/€82 EUR ends on 28 May 2018! The European Transplant Nursing Symposium will bring together staff, nurses, administrators, students, and more for an inspiring transplant nursing educational experience. Earn up to 25 CE hours as you attend sessions directed at your interest and level of practice. Register now and save!
This one-day symposium is designed for nurses, transplant coordinators, and members of allied health groups to become familiar with and update their knowledge about the principles of organ transplantation. Topics include transplant immunology, different aspects and new developments on heart, lung, kidney, pancreas, liver, and intestinal transplantation, infectious disease, and comprehensive care of transplant patients. ITNS member Dr. Joyce A. Trompeta will be presenting a session on “Comprehensive Care of the Transplant Patient” as part of this session. Learn more and register here.
The tenth round of scholarship funding to underrepresented minority nursing students who plan to work as nursing faculty after graduation is now open and accepting applications.
To be eligible for this scholarship program funded by the Johnson & Johnson Campaign for Nursing's Future, applicants must be enrolled full time in a doctoral nursing program or clinically focused master's degree program. Five scholarships in the amount of $18,000 each will be awarded. View more details and access the scholarship application here. The application deadline is May 31, 2018.
Interested in signing up for a Special Interest Group (SIG) listserv? Watch this short video demonstration of how to sign up for a SIG listserv on the ITNS website.
The Huffington Post
When Caleigh Haber was 22, she was told she was too sick for a lung transplant and would die. Her doctors recommended focusing on quality of life with her limited time remaining, and she was given do-not-resuscitate forms. She quit her job as a pastry chef and her mother and brother moved nearby to be with her.
READ MORE
Cancer Network
Sarcopenia may be an important prognostic factor for post-transplant tumor recurrence of advanced hepatocellular carcinoma (HCC). Researchers in Korea, in a study published in Scientific Reports, note that sarcopenia appears to be one of the important host factors modulating tumor recurrence risk after living donor liver transplantation (LDLT) for advanced HCC.
READ MORE
Nurse.org
A substantial portion of qualified nurses are reaching retirement at the same time, creating a sudden deficit that has been hard to fill. At the same time, Baby Boomers, which represent one of the largest generations, has increased demand on the healthcare system as they age and require additional medical care. As a result, the U.S. will need to train one million new nurses by 2022 to meet demands.
READ MORE
Health IT Analytics
Eighty-seven percent of registered nurses (RNs) agreed that non-physician healthcare professionals, including RNs and nurse practitioners, are playing an increasingly important role in patient management and care coordination, according to a University of Phoenix College of Health Professions survey.
Eighty-two percent believe that they will play an even larger role in the overall management of patient care in the next five years.
READ MORE
News-Medical
Lung transplant patients who showed evidence of alcohol use before their transplants spent more time in the hospital and on the ventilator, according to a study by Loyola University Chicago and Loyola Medicine researchers.
The study by Erin M. Lowery, MD, and colleagues is published in the journal Clinical Transplantation.
READ MORE
Medscape Commentary (free login required)
As one of the surgeons performing the most corneal transplants in children at Wills Eye Hospital for the past many years, I am especially eager to learn about anything that will improve the fairly mediocre state of affairs in pediatric keratoplasty.
Corneal transplantation in children is technically difficult, with increased risk for extrusion of the intraocular contents during surgery.
READ MORE
Infectious Disease Advisor
Sofosbuvir-based regimens administered for hepatitis C virus (HCV) recurrence after liver transplantation are safe for the kidneys, according to a multicenter, longitudinal assessment published in Alimentary Pharmacology & Therapeutics.
Sofosbuvir-based direct-acting antiviral regimens are highly efficacious in liver transplant recipients with HCV recurrence.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
